Back
Results - Announcements
Sales decline 6.86% to Rs 606.54 crore
Epigral consolidated net profit rises 87.13% in the June 2025 quarter
02-Aug-2025, 02:18
Net profit of Epigral rose 87.13% to Rs 160.69 crore in the quarter ended June 2025 as against Rs 85.87 crore during the previous quarter ended June 2024. Sales declined 6.86% to Rs 606.54 crore in the quarter ended June 2025 as against Rs 651.20 crore during the previous quarter ended June 2024.
Net profit of Epigral rose 87.13% to Rs 160.69 crore in the quarter ended June 2025 as against Rs 85.87 crore during the previous quarter ended June 2024. Sales declined 6.86% to Rs 606.54 crore in the quarter ended June 2025 as against Rs 651.20 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 606.54 | 651.20 | -7 |
| OPM % | 26.94 | 27.07 | - |
| PBDT | 148.55 | 164.41 | -10 |
| PBT | 107.01 | 130.96 | -18 |
| NP | 160.69 | 85.87 | 87 |
Powered by Capital Market - Live News